MELANOMA, STAGE II
Clinical trials for MELANOMA, STAGE II explained in plain language.
Never miss a new study
Get alerted when new MELANOMA, STAGE II trials appear
Sign up with your email to follow new studies for MELANOMA, STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New biosimilar aims to match keytruda in melanoma fight
Disease control OngoingThis study compares FYB206, a biosimilar (a very similar copy) of the cancer drug Keytruda, to the original Keytruda in 96 adults with stage IIB/IIC or III melanoma that has been completely removed by surgery. The goal is to see if FYB206 stays in the body the same way as Keytrud…
Matched conditions: MELANOMA, STAGE II
Phase: PHASE1 • Sponsor: Formycon AG • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Melanoma Survivors' immunotherapy side effects under the microscope
Knowledge-focused OngoingThis study looks at side effects and symptom burden in people with melanoma who are receiving immunotherapy after surgery. Researchers will track side effects, quality of life, depression, and fatigue over 24 months. They also want to see if certain blood markers are linked to th…
Matched conditions: MELANOMA, STAGE II
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 10:31 UTC